04 October 2023 1 Min Read
Ascendis division exits business rescue
After settling tax troubles with Sars, the firm’s Surgical Innovations segment stays commercially viable on the JSE
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In